Clinical Trials Directory

Trials / Conditions / Renal Neoplasms

Renal Neoplasms

11 registered clinical trials studyying Renal Neoplasms — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAI for Renal Tumors Using Non-Contrast CT
NCT07304492
Fudan University—
Not Yet RecruitingTumor Rupture During Robotic Partial Nephrectomy
NCT07065825
Azienda Ospedaliera Universitaria Integrata Verona—
RecruitingOptimising Renal Tumour Management Through Artificial Intelligence Modules
NCT06714916
Shao Pengfei—
TerminatedPh2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccR
NCT05935748
NiKang Therapeutics, Inc.Phase 2
TerminatedA Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT05119335
NiKang Therapeutics, Inc.Phase 1 / Phase 2
CompletedStudy of Nivolumab for Advanced Cancers in India
NCT03444766
Bristol-Myers SquibbPhase 4
TerminatedA Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With
NCT03165721
National Cancer Institute (NCI)Phase 2
Not Yet RecruitingA CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant
NCT02688491
First Affiliated Hospital, Sun Yat-Sen UniversityN/A
UnknownExtracolonic Findings on Computed Tomography (CT) Colonography
NCT01465425
American College of Radiology Imaging Network—
CompletedSafety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.
NCT00199888
Ludwig Institute for Cancer ResearchPhase 1
CompletedTariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer
NCT00069160
National Cancer Institute (NCI)Phase 2